6th Global Pharma SFE Forum

Fleming Europe15 - 16 March 2011, Lisbon, Portugal.
Following the previous five successful SFE conferences, Fleming Europe announced the 6th Pharma SFE Forum. The conventional conference program has been changed to interactive simulation games, case studies discussions, panel and round table sessions. Global Pharma SFE Forum is focused solely on interaction between attendees and expert presenters.

The 2 Focused Streams (Sales, Marketing, CRM, HR, and Training) will consist of Hands-on Case Studies, Workshops, Simulation presentations and Panel discussions.

Case Studies:

  • Detect Recent Trends and Future of Commercial Model
  • Targeting Effectiveness with right Metrics
  • How to Enjoy Change? Challenge of Merger- Acquisition Process
  • Where do you Spend your Promotional Dollar?
  • Using Marketing Simulation to Drive Brand Awareness
  • Innovative Approaches for Creative Marketing and Increasing Sales Trough Diverse, Multi Channel Initiatives
  • Hiring Pharma Sales Reps: Getting the Process Right
  • The Evolving Training Needs of Pharma Sales Force
  • What they "do" they learn: Most Effective Training For Your Sales Force "Simulation Gaming"
  • Achieving a CRM project success
  • Sales Territory Analysis and Optimization
  • Overcoming Restricted Access to Physicians
  • Using Technology to achieve sales force effectiveness
  • Determining Sales Force Size
  • Motivating and Compensating the Sales Force
  • Discovering Proven Methods to Measure the Impact of your Incentives
  • Value your Sales Talents, Cultural Differences

Workshops:

  • Use the opportunity to interact with presenters face-to-face to ask your questions and brainstorm with your peers.

Keynote:

  • Brand-New Holistic Approach of Pharmaceutical Sales Model

Fleming Europe has gathered almost 20 Vice Presidents, Global Heads and Senior Directors. A special part is an evening event to discover Lisbon and enjoy its finest spring hour.

For further information and registration, please visit:
http://www.sfeforum.com

About Fleming Europe conferences
Fleming Europe conferences are events linking business with intelligence. Carefully designed to provide key strategic business information and the best networking opportunities for the participants, our B2B conferences are highly interactive. Number of delegates from specialized industry sectors - brought together by Fleming Europe - become part of a premium community discussing the questions of the day and enjoying the value of a five star event.

Most Popular Now

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

Time-restricted eating reshapes gene expression th…

Numerous studies have shown health benefits of time-restricted eating including increase in life span in laboratory studies, making practices like intermittent fasting a ...

Incurable liver disease may prove curable

Research led by Associate Professor Duc Dong, Ph.D., has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the li...

Scientists develop a cancer vaccine to simultaneou…

Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women’s ...

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...

500,000 missed out on blood pressure lowering drug…

Nearly half a million people missed out on starting medication to lower their blood pressure during the COVID-19 pandemic, according to research supported by the British ...